Growth Hormone Therapy in Adults with Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is characterized by hyperphagia, obesity if food intake is not strictly controlled, abnormal body composition with decreased lean body mass and increased fat mass, decreased basal metabolic rate, short stature, low muscle tone, cognitive disability, and hypogonadism. In a...
Main Authors: | Karen S. Vogt, Jill E. Emerick |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Diseases |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-9721/3/2/56 |
Similar Items
-
Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
by: Layla Damen, et al.
Published: (2020-06-01) -
Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome
by: Charlotte Höybye, et al.
Published: (2021-02-01) -
Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome
by: Aydilek Dağdeviren Çakır, et al.
Published: (2021-09-01) -
Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome
by: Karlijn Pellikaan, et al.
Published: (2021-07-01) -
Prader Willy’s syndrome diagnosed in extremely obese female adolescent
by: Lešović Snežana
Published: (2017-01-01)